{
    "title": "FDA still skeptical of ALS drug ahead of high-stakes meeting",
    "url": "https://www.dailymail.co.uk/wires/ap/article-11174271/FDA-skeptical-ALS-drug-ahead-high-stakes-meeting.html",
    "date": "2022-09-02",
    "keywords": [
        "drug",
        "fda",
        "approval",
        "review",
        "company",
        "health",
        "case",
        "treatment",
        "amylyx",
        "agency",
        "companys",
        "chance",
        "study",
        "combination",
        "wallach",
        "debilitating",
        "illness",
        "lou",
        "disease",
        "congress",
        "friday",
        "meeting",
        "panel",
        "benefit",
        "life",
        "cambridge",
        "ap",
        "cure",
        "amylyxs",
        "analysis",
        "decision",
        "supplement",
        "university",
        "science",
        "department",
        "washington",
        "drugmaker",
        "opportunity",
        "rallying",
        "cause",
        "march",
        "sclerosis",
        "hospitalization",
        "account",
        "need",
        "seriousness",
        "flexibility",
        "way",
        "product",
        "analyst",
        "marc",
        "note",
        "photo",
        "cohen",
        "left",
        "justin",
        "klee",
        "mass",
        "theyre",
        "maker",
        "nerve",
        "talk",
        "swallow",
        "weight",
        "effect",
        "survival",
        "midstage",
        "trial",
        "implementation",
        "followup",
        "approach",
        "interpretability",
        "rationale",
        "input",
        "hand",
        "end",
        "month",
        "prescription",
        "medication",
        "liver",
        "massachusetts",
        "death",
        "advocacy",
        "founder",
        "homework",
        "isnt",
        "interpreter",
        "part",
        "june",
        "country",
        "position",
        "bioethicist",
        "fernandezlynch",
        "pennsylvania",
        "argument",
        "barrier",
        "trading",
        "matthew",
        "perrone",
        "twitter"
    ],
    "category": [
        "wires",
        "ap"
    ]
}